Representative Director, Chairman and President Ryoichi Nagata appeared on Nikkei CNBC's "Ask the Top"!
- Information
Ryoichi Nagata, Chairman and President of the Company, appeared on the live interview segment "Ask the Top" in the Nikkei CNBC Morning Express broadcast on Tuesday, May 27, 2025.
In the program, he talked about the overview of the CRO business, which is our core business, the TR (Translational Research) business, which is positioned as the third growth engine, the overview of Atzumi™, an acute treatment for migraine that was developed based on our proprietary nasal administration platform technology (SMART) and was approved for marketing by the U.S. Food and Drug Administration (FDA) for the first time, and our medium- to long-term prospects.
You can check the archived video from the link below, so please take a look!
[Nikkei CNBC] Morning Express "Ask the Top" appearance video (broadcast on May 27, 2025)
* Video viewing period: Until May 26, 2026
* Information such as stock prices in the video is as of the broadcast date and time.
